Xeloda is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Capecitabine.
| Product ID | 53808-0411_15601703-7442-48f3-89f4-44fef66b7514 |
| NDC | 53808-0411 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Xeloda |
| Generic Name | Capecitabine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-07-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020896 |
| Labeler Name | State of Florida DOH Central Pharmacy |
| Substance Name | CAPECITABINE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2009-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020896 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-07-01 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| CAPECITABINE | 500 mg/1 |
| SPL SET ID: | a732b303-9bbd-42ba-a7c5-61c21629ba93 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-1100 | Xeloda | capecitabine |
| 0004-1101 | Xeloda | capecitabine |
| 53808-0411 | Xeloda | Xeloda |
| 0054-0271 | Capecitabine | Capecitabine |
| 0054-0272 | Capecitabine | Capecitabine |
| 0093-7473 | Capecitabine | Capecitabine |
| 0093-7474 | Capecitabine | Capecitabine |
| 0378-2511 | Capecitabine | capecitabine |
| 0378-2512 | Capecitabine | capecitabine |
| 16714-467 | CAPECITABINE | CAPECITABINE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XELODA 75241696 2200434 Live/Registered |
Hoffmann-La Roche Inc. 1997-02-13 |